Axogen Financial Statements From 2010 to 2024

AXGN Stock  USD 17.19  1.55  9.91%   
Axogen financial statements provide useful quarterly and yearly information to potential Axogen Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Axogen financial statements helps investors assess Axogen's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Axogen's valuation are summarized below:
Gross Profit
114.4 M
Profit Margin
(0.08)
Market Capitalization
688.3 M
Enterprise Value Revenue
4.0497
Revenue
180.9 M
We have found one hundred twenty available fundamental signals for Axogen Inc, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to validate Axogen's prevailing fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. As of the 23rd of December 2024, Market Cap is likely to grow to about 307.5 M. Also, Enterprise Value is likely to grow to about 347.7 M

Axogen Total Revenue

166.96 Million

Check Axogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.8 M, Interest Expense of 1.6 M or Total Revenue of 167 M, as well as many indicators such as Price To Sales Ratio of 1.75, Dividend Yield of 1.39 or PTB Ratio of 2.91. Axogen financial statements analysis is a perfect complement when working with Axogen Valuation or Volatility modules.
  
Check out the analysis of Axogen Correlation against competitors.

Axogen Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets206.7 M196.8 M103.3 M
Slightly volatile
Short and Long Term Debt Total72.8 M69.3 M34.1 M
Slightly volatile
Other Current Liabilities18 M17.1 M7.7 M
Slightly volatile
Total Current Liabilities32 M30.4 M13.6 M
Slightly volatile
Property Plant And Equipment Net109.5 M104.3 M31.5 M
Slightly volatile
Cash32.6 M31 M24.3 M
Slightly volatile
Non Current Assets Total114.3 M108.8 M33.7 M
Slightly volatile
Cash And Short Term Investments19.8 M31 M43 M
Slightly volatile
Net Receivables26.4 M25.1 M11.5 M
Slightly volatile
Common Stock Shares Outstanding45 M42.9 M28.4 M
Slightly volatile
Liabilities And Stockholders Equity206.7 M196.8 M103.3 M
Slightly volatile
Non Current Liabilities Total74.3 M70.7 M32.5 M
Slightly volatile
Inventory24.2 M23 M10 M
Slightly volatile
Other Stockholder Equity395.4 M376.5 M205.8 M
Slightly volatile
Total Liabilities106.2 M101.2 M46.1 M
Slightly volatile
Property Plant And Equipment Gross123.9 M118 M33.9 M
Slightly volatile
Total Current Assets92.4 M88 M69.5 M
Slightly volatile
Short Term Debt1.5 M1.5 M4.7 M
Pretty Stable
Intangible Assets4.8 M4.5 M1.7 M
Slightly volatile
Other Current Assets9.3 M8.8 M3.4 M
Slightly volatile
Accounts Payable12.4 M11.8 M4.8 M
Slightly volatile
Common Stock Total Equity512 K487.6 K308.9 K
Slightly volatile
Common Stock452.6 K431 K301.2 K
Slightly volatile
Other Liabilities2.6 K2.7 K235.7 K
Slightly volatile
Property Plant Equipment113.1 M107.7 M30.9 M
Slightly volatile
Long Term Debt33.6 M46.6 M29 M
Slightly volatile
Long Term Debt Total79.8 M76 M33.9 M
Slightly volatile
Capital Surpluse210.4 M414.2 M198.3 M
Slightly volatile
Short and Long Term Debt737.9 K776.7 K11 M
Slightly volatile
Net Invested Capital146.9 M142.3 M95.4 M
Slightly volatile
Net Working Capital74.4 M57.6 M68 M
Slightly volatile
Capital Stock451.6 K431 K401.8 K
Slightly volatile
Non Current Liabilities Other2.6 K2.7 K69.2 K
Slightly volatile
Capital Lease Obligations24.2 M22.7 M21.4 M
Slightly volatile

Axogen Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization5.8 M5.6 M2.2 M
Slightly volatile
Interest Expense1.6 M2.8 M2.7 M
Slightly volatile
Total Revenue167 M159 M71.2 M
Slightly volatile
Gross Profit134.3 M127.9 M58.1 M
Slightly volatile
Other Operating Expenses189.5 M180.5 M86.8 M
Slightly volatile
Cost Of Revenue32.7 M31.1 M13.2 M
Slightly volatile
Total Operating Expenses156.8 M149.3 M73.6 M
Slightly volatile
Selling General Administrative36.7 M34.9 M18.6 M
Slightly volatile
Research Development29.7 M28.3 M12 M
Slightly volatile
Selling And Marketing Expenses47.3 M86.1 M40.7 M
Slightly volatile
Interest Income2.5 M2.1 M3.2 M
Slightly volatile
Reconciled Depreciation3.5 M4.9 MM
Slightly volatile

Axogen Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow11.6 M21.5 M23 M
Slightly volatile
Depreciation5.8 M5.6 MM
Slightly volatile
Capital Expenditures15.7 M14.9 M15.7 M
Slightly volatile
End Period Cash Flow38.9 M37 M27.2 M
Slightly volatile
Stock Based Compensation15.1 M14.4 M6.1 M
Slightly volatile
Change To Netincome20.2 M19.2 M8.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.751.84185.0872
Very volatile
Dividend Yield1.391.321.3661
Slightly volatile
Days Sales Outstanding88.6657.72364.6294
Very volatile
Average Payables3.2 M3.1 MM
Slightly volatile
Stock Based Compensation To Revenue0.08610.09070.4848
Slightly volatile
Capex To Depreciation2.682.68655.7084
Pretty Stable
EV To Sales1.982.08245.2159
Very volatile
Inventory Turnover1.291.35261.3694
Pretty Stable
Days Of Inventory On Hand156270297
Pretty Stable
Payables Turnover2.512.64462.9841
Pretty Stable
Sales General And Administrative To Revenue0.360.21980.3688
Slightly volatile
Average Inventory3.1 M2.9 MM
Slightly volatile
Research And Ddevelopement To Revenue0.10.17820.1529
Very volatile
Capex To Revenue0.0960.09380.1452
Slightly volatile
Cash Per Share0.820.72351.4528
Pretty Stable
Days Payables Outstanding76.29138141
Slightly volatile
Income Quality0.160.26320.6996
Slightly volatile
Intangibles To Total Assets0.03520.0230.0236
Slightly volatile
Current Ratio2.752.8926.4128
Slightly volatile
Receivables Turnover6.016.32335.9321
Slightly volatile
Graham Number3.345.04224.5017
Pretty Stable
Capex Per Share0.20.34790.3884
Slightly volatile
Average ReceivablesM8.6 M6.3 M
Slightly volatile
Revenue Per Share2.33.70841.9893
Slightly volatile
Interest Debt Per Share0.61.1531.0774
Slightly volatile
Debt To Assets0.280.23680.4449
Slightly volatile
Operating Cycle201328359
Slightly volatile
Days Of Payables Outstanding76.29138141
Slightly volatile
Ebt Per Ebit0.91.01181.2359
Slightly volatile
Long Term Debt To Capitalization0.280.32760.5103
Slightly volatile
Total Debt To Capitalization0.30.32760.5188
Slightly volatile
Quick Ratio2.032.13555.491
Slightly volatile
Net Income Per E B T1.141.091.0154
Pretty Stable
Cash Ratio0.971.01953.3236
Slightly volatile
Cash Conversion Cycle130190221
Pretty Stable
Days Of Inventory Outstanding156270297
Pretty Stable
Days Of Sales Outstanding88.6657.72364.6294
Very volatile
Free Cash Flow Operating Cash Flow Ratio3.793.60992.1828
Slightly volatile
Fixed Asset Turnover1.451.524717.278
Slightly volatile
Debt Ratio0.280.23680.4449
Slightly volatile
Price Sales Ratio1.751.84185.0872
Very volatile
Asset Turnover0.950.80790.6922
Slightly volatile
Gross Profit Margin0.460.80420.7252
Slightly volatile

Axogen Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap307.5 M292.9 M372.6 M
Slightly volatile
Enterprise Value347.7 M331.1 M390.7 M
Slightly volatile

Axogen Fundamental Market Drivers

Forward Price Earnings43.4783
Cash And Short Term Investments31 M

Axogen Upcoming Events

12th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
12th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Axogen Financial Statements

Axogen investors utilize fundamental indicators, such as revenue or net income, to predict how Axogen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue12.6 K12 K
Total Revenue159 M167 M
Cost Of Revenue31.1 M32.7 M
Stock Based Compensation To Revenue 0.09  0.09 
Sales General And Administrative To Revenue 0.22  0.36 
Research And Ddevelopement To Revenue 0.18  0.10 
Capex To Revenue 0.09  0.10 
Revenue Per Share 3.71  2.30 
Ebit Per Revenue(0.13)(0.14)

Pair Trading with Axogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axogen will appreciate offsetting losses from the drop in the long position's value.

Moving against Axogen Stock

  0.56VNRX VolitionrxPairCorr
  0.4VTAK Catheter PrecisionPairCorr
The ability to find closely correlated positions to Axogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axogen Inc to buy it.
The correlation of Axogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock:
Check out the analysis of Axogen Correlation against competitors.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.33)
Revenue Per Share
4.16
Quarterly Revenue Growth
0.179
Return On Assets
(0.03)
Return On Equity
(0.15)
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.